Cargando…

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation

BACKGROUND: Liver fibrosis accumulation is considered a turnover disease, with formation exceeding degradation, although this hypothesis has never been tested in humans. AIMS: To investigate extracellular matrix (ECM) remodelling in a biopsy‐controlled study of alcohol‐related liver disease (ALD) pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiele, Maja, Johansen, Stine, Gudmann, Natasja S., Madsen, Bjørn, Kjærgaard, Maria, Nielsen, Mette Juul, Leeming, Diana J., Jacobsen, Suganya, Bendtsen, Flemming, Møller, Søren, Detlefsen, Sönke, Karsdal, Morten, Krag, Aleksander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Fibrosis in Alcoholic Liver Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292476/ https://www.ncbi.nlm.nih.gov/pubmed/34428307 http://dx.doi.org/10.1111/apt.16567

Ejemplares similares

PRO‐C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol‐related liver disease
por: Madsen, Bjørn S., et al.
Publicado: (2021)

Mechanisms of fibrosis in acute liver failure
por: He, Yingli, et al.
Publicado: (2015)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)

Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients
por: Nielsen, Mette Juul, et al.
Publicado: (2019)

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
por: Rasmussen, Ditlev Nytoft, et al.
Publicado: (2021)

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
por: Kimer, Nina, et al.
Publicado: (2018)

Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022)

Fortification of alcoholic beverages (12% v/v) with tea (Camellia sinensis) reduces harmful effects of alcohol ingestion and metabolism in mouse model
por: Ochanda, S O, et al.
Publicado: (2016)

Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group
por: Parker, Richard, et al.
Publicado: (2023)

Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver disease
por: Thorhauge, Katrine Holtz, et al.
Publicado: (2022)

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
por: Israelsen, Mads, et al.
Publicado: (2023)

Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause?
por: Leon, David A, et al.
Publicado: (2010)

Does legislation to prevent alcohol sales to drunk individuals work? Measuring the propensity for night-time sales to drunks in a UK city
por: Hughes, Karen, et al.
Publicado: (2014)

Measurable effects of local alcohol licensing policies on population health in England
por: de Vocht, F, et al.
Publicado: (2016)

Alcohol-related mortality in deprived UK cities: worrying trends in young women challenge recent national downward trends
por: Shipton, Deborah, et al.
Publicado: (2013)

Do patients who die from an alcohol-related condition ‘drift’ into areas of greater deprivation? Alcohol-related mortality and health selection theory in Scotland
por: Pulford, Andrew, et al.
Publicado: (2018)

Alcohol industry corporate social responsibility initiatives and harmful drinking: a systematic review
por: Mialon, Melissa, et al.
Publicado: (2018)

Failed Attempts to Improve the Reliability of the Alcohol Visual Probe Task Following Empirical Recommendations
por: Jones, Andrew, et al.
Publicado: (2018)

Impact on Product Appeal of Labeling Wine and Beer With (a) Lower Strength Alcohol Verbal Descriptors and (b) Percent Alcohol by Volume (%ABV): An Experimental Study
por: Vasiljevic, Milica, et al.
Publicado: (2018)

Effect of glass markings on drinking rate in social alcohol drinkers
por: Troy, David M., et al.
Publicado: (2017)

Does Alcohol Cue Inhibitory Control Training Survive a Context Shift?
por: Jones, Andrew, et al.
Publicado: (2020)

Smoking, drinking, diet and physical activity—modifiable lifestyle risk factors and their associations with age to first chronic disease
por: Ng, Ryan, et al.
Publicado: (2020)

Declared funding and authorship by alcohol industry actors in the scientific literature: a bibliometric study
por: Golder, Su, et al.
Publicado: (2020)

Are bottle shops using Twitter to increase advertising or encourage drinking during COVID‐19?
por: Winter, Daniel T., et al.
Publicado: (2021)

Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry
por: Ye, Xiao‐Fei, et al.
Publicado: (2023)

A mystery-shopping study to test enforcement of minimum legal purchasing age in Lithuania in 2022
por: Miščikienė, Laura, et al.
Publicado: (2023)

A comparative study of industry responses to government consultations about alcohol and gambling in the UK
por: Bhuptani, Saloni, et al.
Publicado: (2023)

Support for evidence-based alcohol policy in Ireland: results from a representative household survey
por: Calnan, Susan, et al.
Publicado: (2023)

Children with problem-drinking parents in a Swedish national sample: is the risk of harm related to the severity of parental problem drinking?
por: Ramstedt, Mats, et al.
Publicado: (2023)

Short-term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis
por: Osman, Leyla P, et al.
Publicado: (2009)

Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis
por: Jackson, Abaigeal D, et al.
Publicado: (2011)

Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
por: Wainwright, C E, et al.
Publicado: (2009)

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
por: Schuster, Antje, et al.
Publicado: (2013)

Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
por: Knibbs, Luke D, et al.
Publicado: (2014)

Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants
por: Nguyen, The Thanh-Diem, et al.
Publicado: (2014)

Shortened Lung Clearance Index is a repeatable and sensitive test in children and adults with cystic fibrosis
por: Hannon, David, et al.
Publicado: (2014)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
por: Clancy, J P, et al.
Publicado: (2013)

Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age?
por: Thia, Lena P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tjt2d484mbmj94crcpqj6j7gv8